Tumor invasion and metastasis: an imbalance of positive and negative regulation.
about
The detection, treatment, and biology of epithelial ovarian cancer14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transitionAstrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisExpression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cellsThe proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoidsTransforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-betaThe heterogeneity of store-operated calcium entry in melanomaExosomes: The Link between GPCR Activation and Metastatic Potential?Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategyThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerDiscovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase InhibitorsMetastasis suppressor genes at the interface between the environment and tumor cell growthPEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesisMechanistic insights into mode of action of novel natural cathepsin L inhibitors.Comparative mechanisms of cancer cell migration through 3D matrix and physiological microtracksActivity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancerTumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma.Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cellsMesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell linesGlabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cellsThe potential roles of aquaporin 4 in malignant gliomasAlterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.Cell surface molecules and their prognostic values in assessing colorectal carcinomas.A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancerDefining the role of laminin-332 in carcinoma.Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasionTumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.Proliferation and invasion: plasticity in tumor cells.Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.Matrix metalloproteinase-2 promotes αvβ3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin.Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells.Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivatives.Silencing of diphthamide synthesis 3 (Dph3) reduces metastasis of murine melanoma.Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53Tumor growth in complex, evolving microenvironmental geometries: a diffuse domain approach.Protease nexin-1 expression is altered in human breast cancer.Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.
P2860
Q21198791-3D57E37A-0900-4008-BBAF-B0B78BE4AEB6Q24313042-E5D998CC-65E6-4154-B8E5-A3CC750FF80FQ24321673-80C09206-2B6F-4E18-A923-C90DDF8FEB75Q24647453-360AD31E-07D0-45E2-ABA2-69B020761595Q24792397-0C2C2F46-538D-485A-A2C9-09E78200C714Q24793319-AA63F93E-21B4-4265-8817-F81948FC7ED2Q26740276-53636E63-1684-4574-A8E3-AB268C55A88DQ26752479-DF5188D6-3A3B-4D52-9027-9180D51714F6Q26863340-7973E055-740C-4E46-8D5C-E1FEC38D8AF6Q27004958-C268B4EA-E7EC-4201-832B-DF055E8A2ED6Q27684175-E745D274-29C4-49BF-AE30-3DACC83A1F6FQ28394526-423A8874-7432-4C73-A90A-E17CD213A1E7Q28571724-3ADC3833-261C-4E61-B950-71468F595883Q30579667-2E9F2375-F5A8-4B0F-8785-8171C1FEFB56Q30627878-FFB6960B-33B1-40D6-B35C-47F7D0F8555DQ33254343-5C457353-9C30-48DD-99E7-D7F04FB74B33Q33350682-16713744-6C63-488E-963F-C64B820A6543Q33520086-66EF69B7-26CD-4EFE-B49D-8EFAAACAF2AFQ33529871-F70A49B8-9F2C-41A4-9166-72B7E20C7AADQ33648915-1E70EC41-5B29-464F-B127-BBAAC3F8C39DQ33746852-09878BBA-BEB8-4BC3-A4F7-F6538CC1E19CQ33762106-A16652A3-2F7F-479B-ACF3-58B902C5D93FQ33787986-766E36BE-3088-4590-934B-ED0EAD9A3056Q33818072-2507E67B-F966-4EAA-A015-2B6D9045AE07Q33849094-57484871-BB90-493B-8576-5B9C1B598FE0Q33875126-BFEA32BA-1512-4A3B-9C5F-FB2DF35D0F8FQ33892014-119E379A-4346-4D96-AC81-BBEDAD8CC1CCQ33899892-F062110B-207F-4369-9097-DD92EF5AD566Q33906737-E4B847EF-271C-42A9-B5C2-E38649DD4D8AQ33943198-B86485C1-17D3-476A-AC4F-0597729CFA00Q34293732-A208FB91-9A8C-46CC-9DCD-7C7838CB6242Q34358663-68D5ED43-0BDB-44AE-9080-9898D94BF99AQ34372155-C5C6458D-C4C8-48E7-9409-DA28FFD52CDCQ34432994-266B8A8F-E1C3-4ED3-8D94-79CAC6710FBFQ34490844-82A2A810-C633-4D9E-B720-8210B64F5115Q34581422-BD292A50-E168-46AD-8019-E1B2544CDC69Q34589775-5BE55543-56AE-4156-A211-EEAF345BC1B3Q34614923-5520718B-E966-406A-B60C-1D9E48032831Q34768102-AB1654F0-0004-4E52-AB6F-B0F895E193E2Q34779402-BB88B8D6-A985-4E82-A363-DA92C3856DAD
P2860
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
@en
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
@nl
type
label
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
@en
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
@nl
prefLabel
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
@en
Tumor invasion and metastasis: an imbalance of positive and negative regulation.
@nl
P1433
P1476
Tumor invasion and metastasis: an imbalance of positive and negative regulation
@en
P2093
Stetler-Stevenson WG
P304
5054s-5059s
P407
P433
P577
1991-09-01T00:00:00Z